3 completed, 1 unknown. 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 1 | Unknown 1 |
Follow Inhaled loxapine: new trials by email Literature Review of Inhaled loxapine trials Research Report on Inhaled loxapine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Staccato Loxapine (ADASUVEĀ®) for Inhalation Inhaled loxapine, Inhaled placebo - Psychomotor Agitation, Schizophrenia | Phase 3 | Unknown | Lee's Pharmaceutical Limited | 150 | 2019-12-01 | 2019-11-05 |
| Staccato Loxapine Pulmonary Safety in Patients With COPD Inhaled Loxapine, Inhaled Placebo - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Alexza Pharmaceuticals, Inc. | 53 | 2009-06-01 | 2017-03-14 |
| Staccato Loxapine Thorough QT/QTc Study Inhaled loxapine, Inhaled placebo, Oral moxifloxacin - Thorough QT/QTc Study | Phase 1 | Completed | Nova Pneuma Inc. | 48 | 2009-04-01 | 2026-04-22 |
| Staccato Loxapine Pulmonary Safety in Healthy Volunteers Inhaled Placebo, Inhaled Loxapine - Healthy | Phase 1 | Completed | Alexza Pharmaceuticals, Inc. | 30 | 2008-11-01 | 2019-03-11 |
Bipolar Disorder (1) · Psychomotor Agitation (1) · Pulmonary Disease, Chronic Obstructive (1) · Schizophrenia (1)
Alexza Pharmaceuticals, Inc. (2) · Lee's Pharmaceutical Limited (1) · Nova Pneuma Inc. (1)
United States (3)
David S. Miller, MD (1) · Mildred D. Gottwald, PharmD (1) · Randall R. Stoltz, MD (1)